LIPICARD

1. All Details: Specifications
Dosage Form: Oral capsules.
Storage Conditions: Store protected from moisture, at a temperature not exceeding 30°C.
Batch Number (BATCH No.): 28027640
Manufacturing Date (MFG. DATE): 12/2025
Expiry Date (EXPIRY DATE): 11/2027
Manufacturing License Number: Mfg. Lic. No.: MNB/06/291
Maximum Retail Price (M.R.P.): Rs. 275.95 per 10 capsules (indicated as “M.R.P. Rs. 275.95/10 CAPS. (INCL. OF ALL TAXES)”).
Internal Material Code: 3017720
2. General
Brand: LIPICARD® (also printed in Devanagari script as लिपिकार्ड).
Generic Name: Fenofibrate Capsules IP 200 mg
Quantity: 10 Capsules per blister pack (indicated by “10 Capsules” and “10 CAPS.”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the “Rx” symbol and the bright red statutory Schedule H prescription caution box).
Form Factor: Blister strip containing solid oral capsules.
Maximum Shelf Life: 1 year and 11 months (from December 2025 to November 2027).
Food Preference / FSSAI: Not Applicable. This is an allopathic, therapeutic prescription medication meant for clinical metabolic regulation, not a commercial dietary supplement or food item. It falls strictly under national drug control frameworks instead of the FSSAI food authority, and it does not display vegetarian or non-vegetarian food preference symbols.
3. Product Details: Ingredients
Each capsule contains:
Fenofibrate IP (Micronised): 200 mg
Excipients: q.s. (Quantity Sufficient)
Capsule Shell: Approved colours used in empty capsule shell.
4. Directions: How to Use
Dosage: As directed by the Physician.
Administration Frequency Note: The packaging features a prominent secondary instruction stating “ONCE A DAY”.
Statutory Warning Label:
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: LIPICARD® is an oral lipid-regulating prescription medication. Its active pharmaceutical ingredient is micronised Fenofibrate, a fibric acid derivative. The micronisation process enhances the drug’s solubility and dissolution rate in the gastrointestinal tract. It works primarily by activating peroxisome proliferator-activated receptor alpha (PPAR$\alpha$), which accelerates the clearance of triglycerides and very-low-density lipoproteins (VLDL) from the blood plasma. It is standardly prescribed by medical professionals to treat severe hypertriglyceridemia and mixed dyslipidemia.
Visual Presentation: The product comes in a silver metallic blister strip featuring ten distinct capsule cavities designed to safeguard the medication against ambient humidity and degradation. The packaging is stylized with a contrasting red caution block for safety warnings, bold black font for tracking parameters, and the distinctive red oval corporate insignia of USV.
6. Manufacturer Information
Mfd. by: USV Private Limited
Factory Address: Plot No. 4, 5A, 5B, 6 & 7E, HPSIDC Indl. Area, Baddi, District: Solan, Himachal Pradesh – 173 205.
7. Marketed By
Marketed by: USV Private Limited